FDA Greenlights Long-awaited Sunscreen After 25 Years
WHO:
Ynetnews - U.S. Health Secretary Robert F. Kennedy Jr. stated that bemotrizinol has been used safely in Europe for decades.
Ynetnews - Dr. Mike Davis is the acting director of the FDA’s drug evaluation center.
Ynetnews - David Andrews is the chief scientist at the Environmental Working Group (EWG).
The Cut - Mentioned popular sunscreen brands including Bioré, Beauty of Joseon, and La Roche-Posay.
WHAT:
Ynetnews - Bemotrizinol will initially be sold in the U.S. by Dutch manufacturer DSM Nutritional Products under the brand name Parsol Shield, launching later this year.
Ynetnews - After an 18-month exclusivity period, other manufacturers will be able to incorporate bemotrizinol into their products.
Ynetnews - A study by the Environmental Working Group found that U.S. sunscreen products provide on average only 24% of the UVA protection implied by their SPF rating.
Ynetnews - Out of 550 sunscreen products recommended in the EWG 2026 report, 497 are primarily mineral-based.
Ynetnews - The FDA approved bemotrizinol, a new sunscreen ingredient, after a 25-year delay.
Ynetnews - Bemotrizinol protects against both UVA and UVB radiation and is approved for use in adults and children from six months of age at concentrations of up to 6%.
Ynetnews - The approval allows bemotrizinol to be sold in the U.S. by Dutch manufacturer DSM Nutritional Products under the brand name Parsol Shield, launching later this year.
Ynetnews - The FDA has not approved a new sunscreen filter since 1999.
WHERE:
Ynetnews - Bemotrizinol has been widely used in Europe and Israel since 1999.
Ynetnews - The FDA is a U.S. government agency.
WHEN:
Ynetnews - Bemotrizinol was first submitted for FDA approval in 2005.
Ynetnews - The ingredient became the first to go through an accelerated approval pathway authorized by Congress in 2020.
Ynetnews - After an 18-month exclusivity period, other manufacturers will be able to incorporate bemotrizinol into their products.
WHY:
Ynetnews - The approval aligns with the Trump administration’s Make America Healthy Again (MAHA) initiative, under which the FDA has pledged to advance innovation in sunscreen products and improve regulatory processes that have lagged behind other countries.
Ynetnews - The approval aligns with the Trump administration’s Make America Healthy Again (MAHA) initiative to advance innovation in sunscreen products.
Ynetnews - The approval was prompted by limitations in U.S.-made sunscreens, which primarily protect against UVB rays but are less effective against UVA rays.
HOW:
Ynetnews - The approval process was modernized to apply sound science to regulatory decisions.
Ynetnews - The FDA's approval process for bemotrizinol was delayed due to heavy bureaucracy regarding over-the-counter drug ingredients.
Ynetnews - The approval process was modernized to apply sound science to regulatory decisions.
(UPDATED June 11, 2026 10:12 UTC)
Bemotrizinol will soon be available in the U.S. under the brand name Parsol Shield, thanks to Dutch manufacturer DSM Nutritional Products, with a launch expected later this year. Following an 18-month exclusivity period, other manufacturers will be able to include bemotrizinol in their sunscreen products, which comes as part of the Trump administration’s initiative to enhance sunscreen innovation and regulatory processes. A recent study by the Environmental Working Group revealed that U.S. sunscreen products provide, on average, only 24% of the UVA protection suggested by their SPF ratings, highlighting the need for improved formulations.
--
(UPDATED June 11, 2026 08:31 UTC)
The FDA has approved bemotrizinol, a new sunscreen ingredient that protects against both UVA and UVB radiation, after a lengthy 25-year delay, marking the first new sunscreen filter approved since 1999. This ingredient, which has been safely used in Europe and Israel for decades, will be sold in the U.S. under the brand name Parsol Shield by Dutch manufacturer DSM Nutritional Products, with a launch planned for later this year. The approval aligns with the Trump administration’s Make America Healthy Again initiative, aiming to enhance innovation in sunscreen products to address the limitations of U.S.-made sunscreens.